CRNN and cancer: Altogether, Cornulin holds great promise as a molecular biomarker that can objectively and accurately diagnose several types of cancers, determine the malignant potential of precursor lesions, predict clinical outcomes, monitor disease progression and recurrence, and ultimately help guide treatment options for patients afflicted with these malignancies.